Healthcare industry
-
New rules could see 13,000 people with disabilities and long-term health needs forced into care homes. This is treating people as objects to be stored
-
Democrats raise concern over health secretary nominee, who bought and sold health-related stocks while he was an influential voice on healthcare policy
-
The acting health minister, Arthur Sinodinos, is expected to approve a 5% increase to premiums next month
-
Senate voted 51-48 on a Republican-backed budget measure that eases the way for action on subsequent repeal legislation as soon as next month
-
King’s Fund says rising workload and squeezed revenue means NHS England needs to focus on preventative medicine
-
ConvaTec, little-known supplier of ‘urological drainage products’, joins the big names in the latest reshuffle
-
Letters: The convalescent home was run by methods that were, even by the standards of the day, harsh and spartan
-
The health service is increasingly relying on small businesses to meet its needs. But how can entrepreneurs find a way in?
-
Chairman says financial peformance has stabilised but ‘historical underfunding’ continues to pile pressure on sector
-
A new medical device that give a patient’s own blood back to them could, its makers say, save lives and money, and is already being used around the world. So why isn’t the NHS buying any of them?
-
Australian Medical Association chief calls on insurers to stop selling inappropriate policies and says behaviour of some risks undermining system
-
Letters: For private companies profits come before patients, and any system that has to fork out to shareholders has less to spend on care
-
Obamacare price hikes show that now is the time to be bold
Celine GounderIf Hillary Clinton wins the election, she’ll probably have a small window to expand healthcare access before the partisan gridlock kicks in -
UK drug firm reaps benefits of falling pound and prepares to welcome new chief
-
British multinational is accused of ‘shamelessly preying on patients in need of help’ by keeping Suboxone, a drug used to treat addiction, at an inflated price
-
The country’s devastating economic downturn is ravaging its hospitals, where acute shortages threaten to reverse decades of progress
Topics
- Health (Society)
- NHS
- Social care
- Private health insurance
- Health (Australia news)
- Public services policy
- Hospitals
- Health policy
- Reckitt Benckiser
- US politics
- Pharmaceuticals industry
- Stock markets
- Business (Australia)
- Private healthcare
- Health & wellbeing
- Donald Trump
- Older people
- Services sector
- Economics
- Nursing
Durex maker moves into baby food with $16.6bn purchase